<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-30T00:49:04Z</responseDate><request verb="GetRecord" identifier="oai:bayburt-rdlopen.rawdatalibrary.net:bayburt/10831" metadataPrefix="oai_dc">https://bayburt-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:bayburt-rdlopen.rawdatalibrary.net:bayburt/10831</identifier><datestamp>2026-10-29T19:41:09Z</datestamp><setSpec>openaire</setSpec><setSpec>com_bayburt_10000</setSpec><setSpec>col_bayburt_10001</setSpec><setSpec>com_bayburt_10007</setSpec><setSpec>col_bayburt_10226</setSpec><setSpec>col_bayburt_10225</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>The ARK2N (C18ORF25) Genetic Variant Is Associated with Muscle Fiber Size and Strength Athlete Status</dc:title><dc:creator>Çigirtas, Rukiye</dc:creator><dc:creator>Bulgay, Celal</dc:creator><dc:creator>Kazan, Hasan Hueseyin</dc:creator><dc:creator>Akman, Onur</dc:creator><dc:creator>Sporis, Goran</dc:creator><dc:creator>John, George</dc:creator><dc:creator>Yusupov, Rinat A.</dc:creator><dc:creator>Sultanov, Rinat I.</dc:creator><dc:creator>Zhelankin, Andrey V.</dc:creator><dc:creator>Semenova, Ekaterina A.</dc:creator><dc:creator>Larin, Andrey K.</dc:creator><dc:creator>Kulemin, Nikolay A.</dc:creator><dc:creator>Generozov, Edward V.</dc:creator><dc:creator>Jurko, Damir</dc:creator><dc:creator>Ahmetov, Ildus I.</dc:creator><dc:subject>polymorphism</dc:subject><dc:subject>genotype</dc:subject><dc:subject>gene expression</dc:subject><dc:subject>SNP</dc:subject><dc:subject>athlete status</dc:subject><dc:subject>weightlifting</dc:subject><dc:subject>sport</dc:subject><dc:subject>molecular physiology</dc:subject><dc:subject>muscle hypertrophy</dc:subject><dc:subject>skeletal muscle</dc:subject><dc:description>Background: Data on the genetic factors contributing to inter-individual variability in muscle fiber size are limited. Recent research has demonstrated that mice lacking the Arkadia (RNF111) N-terminal-like PKA signaling regulator 2N (Ark2n; also known as C18orf25) gene exhibit reduced muscle fiber size, contraction force, and exercise capacity, along with defects in calcium handling within fast-twitch muscle fibers. However, the role of the ARK2N gene in human muscle physiology, and particularly in athletic populations, remains poorly understood. The aim of this study was threefold: (a) to compare ARK2N gene expression between power and endurance athletes; (b) to analyze the relationship between ARK2N gene expression and muscle fiber composition; and (c) to investigate the association between the functional variant of the ARK2N gene, muscle fiber size, and sport-related phenotypes. Results: We found that ARK2N gene expression was significantly higher in power athletes compared to endurance athletes (p = 0.042) and was positively associated with the proportion of oxidative fast-twitch (type IIA) muscle fibers in untrained subjects (p = 0.017, adjusted for age and sex). Additionally, we observed that the ARK2N rs6507691 T allele, which predicts high ARK2N gene expression (p = 3.8 x 10-12), was associated with a greater cross-sectional area of fast-twitch muscle fibers in strength athletes (p = 0.015) and was over-represented in world-class strength athletes (38.6%; OR = 2.2, p = 0.023) and wrestlers (33.8%; OR = 1.8, p = 0.044) compared to controls (22.0%). Conclusions: In conclusion, ARK2N appears to be a gene specific to oxidative fast-twitch myofibers, with its functional variant being associated with muscle fiber size and strength-athlete status.</dc:description><dc:publisher>MDPI</dc:publisher><dc:date>2024-12</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/bayburt/10831</dc:identifier><dc:identifier>https://doi.org/10.3390/metabo14120684</dc:identifier><dc:identifier>2218-1989</dc:identifier><dc:language>en</dc:language><dc:relation>METABOLITES</dc:relation><dc:rights>info:eu-repo/semantics/closedAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://bayburt-rdlopen.rawdatalibrary.net/tr/items/bayburt/10831</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>